Palantir's U.S. Revenue Soars 119% as Commercial Revenue Surpasses Government Revenue for the First Time. Here's Why Its Growth Is Still Surging, Even as Other AI Stocks Falter

Palantir reported third-quarter revenue of $2.3 billion, up 96% year over year and 20% quarter over quarter, beating the $2.2 billion consensus; EPS of $0.44 also exceeded the $0.41 estimate. U.S. commercial revenue rose 148% to $984 million, and management raised its full-year revenue growth forecast to roughly 91% from 82%. The article highlights strong cash generation and customer expansion but notes the stock trades at 125 times earnings, leaving it vulnerable to a sharp rerating if execution falters.

Analysis

The key question is whether reported growth is becoming durable contracted demand or is being pulled forward by unusually strong expansion within existing accounts. High net retention supports the former, but total contract value growth is much slower than the revenue trajectory; that divergence is a reason to track conversion, renewals, and new-customer wins rather than extrapolate the latest growth rate. The U.S. commercial remaining-deal-value figure is encouraging, but it is not equivalent to signed, near-term revenue.

Near term, a large earnings beat may not be enough to support the shares if investors were positioned for exceptional execution: the post-report reaction and subsequent estimate revisions matter more than the beat itself. Over 1–3 months, watch commercial bookings, customer additions, and whether guidance is met without relying mainly on expansion from current customers. Over 6–18 months, successful deployment could pressure legacy analytics vendors and some implementation work, while also inviting competition from cloud platforms and specialist AI providers. The principal risk is not just slower AI spending; it is that customers use competing tools or internal teams to capture value without sustaining Palantir’s expansion rates.

The bullish article’s PEG framing is not a reliable valuation floor: it assumes high growth persists and does not price the severity of a duration-stock rerating if estimates reset. Conversely, strong customer expansion and cash generation could make a premium defensible if bookings confirm the growth. Treat reported metrics as company-reported until checked against filings; this is a high-expectations setup, not a clean low-risk beat.

Key Decisions for Investors

• Avoid chasing the initial earnings move. For investors seeking exposure, scale in over several weeks rather than making a full-position entry; the risk/reward depends heavily on whether growth and margins persist.
• Use a confirmation trigger before adding: look for continued strength in U.S. commercial bookings and customer additions alongside revenue, not revenue growth alone. If those measures weaken or guidance is cut, reduce exposure; that would challenge the conversion thesis.
• Watch the gap between contract-value growth and revenue growth in the next filing. If revenue remains strong but bookings and remaining deal value fail to validate forward demand, treat the acceleration as less durable and reassess the premium.
• Do not rely on the cited PEG ratio as evidence of undervaluation. Before sizing a position, verify the current valuation, forward estimates, and reported cash-flow definitions; those inputs are not sufficient here to set a price target or options trade.